Profil
Kent Gordon has held director positions at Techcyte, Inc. and NanoSpot ai, Inc. He is currently employed as a Director at Techcyte, Inc. and NanoSpot ai, Inc.
Postes actifs de Kent Gordon
| Sociétés | Poste | Début |
|---|---|---|
Techcyte, Inc.
 Techcyte, Inc. Packaged SoftwareTechnology Services Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013. | Directeur/Membre du Conseil | 28/05/2020 |
Nanospot Ai, Inc
 Nanospot Ai, Inc Packaged SoftwareTechnology Services NanoSpot ai, Inc is a company that provides a point-of-care and home testing platform using agglutination and artificial intelligence-based interpretation. The company is based in Salt Lake City, UT. The company's innovative test accurately detects the levels of COVID antibodies in just a few minutes, pain-free, and affordably priced. The test allows anyone to access the levels of their COVID antibodies via a phone screen. The company was founded in 2022 by Hans Haecker, Vanessa Redecke, Mark E. Astill. Rian Wendling has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Techcyte, Inc.
Techcyte, Inc. Packaged SoftwareTechnology Services Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013. | Technology Services |
Nanospot Ai, Inc
Nanospot Ai, Inc Packaged SoftwareTechnology Services NanoSpot ai, Inc is a company that provides a point-of-care and home testing platform using agglutination and artificial intelligence-based interpretation. The company is based in Salt Lake City, UT. The company's innovative test accurately detects the levels of COVID antibodies in just a few minutes, pain-free, and affordably priced. The test allows anyone to access the levels of their COVID antibodies via a phone screen. The company was founded in 2022 by Hans Haecker, Vanessa Redecke, Mark E. Astill. Rian Wendling has been the CEO of the company since 2021. | Technology Services |